How would you treat an isolated para-aortic lymph node endometrial cancer recurrence following a prolonged disease free interval previously treated with surgery, chemotherapy, and radiation therapy, if it is located outside of the previously irradiated field?  

How does histology and/or molecular testing change your approach? How does the length of the disease free interval change your approach?



Answer from: Radiation Oncologist at Community Practice